share_log

Dawson James Initiates Coverage On Zomedica With Buy Rating, Announces Price Target of $6

Dawson James Initiates Coverage On Zomedica With Buy Rating, Announces Price Target of $6

道森詹姆斯起始覆蓋 Zomedica 與購買評級, 宣布目標價格為 $6
Benzinga Real-time News ·  2023/01/06 21:26

Dawson James analyst Jason Kolbert initiates coverage on Zomedica (AMEX:ZOM) with a Buy rating and announces Price Target of $6.

道森詹姆斯分析師傑森·科爾伯特啟動對佐美迪卡覆蓋 (AMEX: ZOM) 與買入評級,並宣布目標價 $6.

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論